Business & Consumer Services » Business Services | Syngene International Ltd.

Syngene International Ltd. | Ownership

Companies that own Syngene International Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Thélème Partners LLP
9,000,000
4.5%
9,000,000
3.22%
09/30/2017
UTI Asset Management Co. Ltd. (Investment Management)
2,611,951
1.31%
227,841
0.23%
08/31/2018
HSBC Global Asset Management (Hong Kong) Ltd.
1,722,151
0.86%
-167,284
0.16%
12/31/2017
Aberdeen Asset Management (Asia) Ltd.
1,464,000
0.73%
1,464,000
0.06%
05/31/2018
The Vanguard Group, Inc.
1,324,792
0.66%
-7,700
0%
07/31/2018
Reliance Nippon Life Asset Management Ltd. (Invt Mgmt)
1,041,752
0.52%
502,358
0.06%
08/31/2018
Aberdeen Asset Managers Ltd.
892,000
0.45%
200,000
0.01%
09/11/2018
Jupiter Asset Management Ltd.
868,610
0.43%
3,335
0.02%
02/28/2018
OppenheimerFunds, Inc.
752,279
0.38%
-559,501
0%
03/31/2018
Canara Robeco Asset Management Co. Ltd.
519,289
0.26%
0
0.4%
07/31/2018

About Syngene International

View Profile
Address
Biocon Park , Plot 2&3, Phase-IV
Bangalore Karnataka 560099
India
Employees -
Website http://www.syngeneintl.com
Updated 09/14/2018
Syngene International Ltd. operates as a contract research organization, which provides discovery and development services for novel molecular entities. Its services include discovery chemistry, discovery biology, safety assessment, large molecule development, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, and clinical development. The company was founded on November 18, 1993 and is headquartered in Bangalore, India.